What insurance policy changes affect CPT 90483?

There are 6 tracked policy changes affecting CPT 90483, including updates from Aetna, Independence Blue Cross, NY Medicaid. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 90483?

Payers that have issued tracked updates for CPT 90483 include: Aetna, Independence Blue Cross, NY Medicaid.

How do I get notified when CPT 90483 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 90483. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 90483?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

90483 — A healthcare provider discusses immunizations with you without actually giving you a shot, when multiple vaccines are involved.: Insurance Policy Changes

90483 Insurance Policy Changes

CPT 90483, in plain terms, covers A healthcare provider discusses immunizations with you without actually giving you a shot, when multiple vaccines are involved. CPT 90483 is referenced in 6 tracked payer policy changes from Aetna, Independence Blue Cross, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 90483 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Medium impact

Pneumococcal Vaccines (CPB 0037, reviewed 2026-10-06)

Aetna·Identified Oct 8, 2026

Aetna's Pneumococcal Vaccines policy (CPB 0037) reviewed on 2026-10-06 establishes medical necessity coverage for FDA-approved pneumococcal conjugate vaccines (PCV15, PCV20, PCV21) and pneumococcal polysaccharide vaccine (PPSV23) according to CDC/ACIP recommendations across multiple age groups and risk categories. The policy specifies distinct coverage pathways for infants/children, adults 19-49 years, adults 50+ years, and adults 65+ years with shared clinical decision-making options. No source-stated effective date is provided; this appears to be a policy review update with no specific implementation deadline identified.

90483 Insurance Policy Changes

Pneumococcal Vaccines (CPB 0037, reviewed 2026-03-02)

00.01.52z, Bundled Procedure Codes

Childhood Vaccine Counseling

Dengue Vaccine (CPB 1010, reviewed 2026-02-25)

Influenza Vaccines (CPB 0035, reviewed 2026-10-08)

Pneumococcal Vaccines (CPB 0037, reviewed 2026-10-06)